10:58 AM EST - CROP INFRASTRUCTURE CORP. : Announced today its 49% owned subsidiary Elite Ventures is nearing completion of a 1,600 square foot genetics, tissue culturing and micropropagation laboratory at the company's Nevada Farms. The objective of the team and the lab will be to provide 10,000,000 plant starts for the company's 2,115 acres of CBD farms. By propagating in the lab, the company will save approximately $3.0 Million in seed and planting costs for the 2019 season. The laboratory team's objective, beyond saving on planting costs, is the mandate of developing proprietary genetics to maximize yield and provide the company a Global edge with specific attentions paid to the over 100 other photocannabinoids beginning with cannabinol (CBN) and cannabigerol (CBG). Cannabis industry analysts, The Brightfield Group, estimate the hemp-CBD market alone could reach $22-billion by 2022. CROP CEO, Michael Yorke, stated: "The development of this genetics and micropropagation lab is further demonstration of our team's dedication to keeping our genetics portfolio and brands at the fore front of this industry. Teams worked steadily through the later part of the year and Holiday season on the construction and development of this lab which will save the company and our stakeholders a significant amount in 2019 and beyond." CROP INFRASTRUCTURE CORP.
shares CROP:CNX are trading up 4.17 percent at $0.38.
